Lee M. Silver

Last updated • 1 min readFrom Wikipedia, The Free Encyclopedia

Lee M. Silver (born 1952) is an American biologist. He is a professor at Princeton University in the Department of molecular biology and the Princeton School of Public and International Affairs. He also has joint appointments in the Program in Science, Technology, and Environmental Policy, the Center for Health and Wellbeing, the Office of Population Research, and the Princeton Environmental Institute, all at Princeton University.

Contents

Contributions

Silver is the author of the book Remaking Eden: How Genetic Engineering and Cloning Will Transform the American Family (1998). In the book he takes a positive view on human cloning, designer babies and similar prospects. In this book he coined the term reprogenetics to describe the prospective fusion of reproductive technologies and genetics, which will allow positive eugenic actions on an individual level.[ citation needed ]

Silver's most recent book was Challenging Nature: The Clash of Science and Spirituality at the New Frontiers of Life (June 2006).[ citation needed ]

Silver is the co-founder of GenePeeks, a genetic research company which owns a simulation for screening genetic disorders. [1]

See also

Related Research Articles

<span class="mw-page-title-main">Cloning</span> Process of producing individual organisms with identical genomes

Cloning is the process of producing individual organisms with identical genomes, either by natural or artificial means. In nature, some organisms produce clones through asexual reproduction; this reproduction of an organism by itself without a mate is known as parthenogenesis. In the field of biotechnology, cloning is the process of creating cloned organisms of cells and of DNA fragments.

<span class="mw-page-title-main">Eugenics</span> Effort to improve purported human genetic quality

Eugenics is a set of beliefs and practices that aim to improve the genetic quality of a human population. Historically, eugenicists have attempted to alter the frequency of various human phenotypes by inhibiting the fertility of people and groups they considered inferior, or promoting that of those considered superior.

<span class="mw-page-title-main">Human cloning</span> Creation of a genetically identical copy of a human

Human cloning is the creation of a genetically identical copy of a human. The term is generally used to refer to artificial human cloning, which is the reproduction of human cells and tissue. It does not refer to the natural conception and delivery of identical twins. The possibilities of human cloning have raised controversies. These ethical concerns have prompted several nations to pass laws regarding human cloning.

<span class="mw-page-title-main">Clonaid</span> Human cloning organization

Clonaid is an American-based human cloning organization, registered as a company in the Bahamas. Founded in 1997, it has philosophical ties with the UFO religion Raëlism, which sees cloning as the first step in achieving immortality. On December 27, 2002, Clonaid's chief executive, Brigitte Boisselier, claimed that a baby clone, named Eve, was born. Media coverage of the claim sparked serious criticism and ethical debate that lasted more than a year. Florida attorney Bernard Siegel tried to appoint a special guardian for Eve and threatened to sue Clonaid, because he was afraid that the child might be treated like a lab rat. Siegel, who heard the company's actual name was not Clonaid, decided that the Clonaid project was a sham. Bioethicist Clara Alto condemned Clonaid for premature human experimentation and noted the high incidence of malformations and thousands of fetal deaths in animal cloning.

<span class="mw-page-title-main">GloFish</span> Brand of genetically modified fluorescent fish

The GloFish is a patented and trademarked brand of fluorescently colored genetically modified aquarium fish. They have been created from several different species of fish: zebrafish were the first GloFish available in pet stores, and recently the black tetra, tiger barb, rainbow shark, Siamese fighting fish, X-ray tetra, and most recently bronze corydoras have been added to the lineup. They are sold in many colors, trademarked as "Starfire Red", "Moonrise Pink", "Sunburst Orange", "Electric Green", "Cosmic Blue", and "Galactic Purple", although not all species are available in all colors. Although not originally developed for the ornamental fish trade, it is one of the first genetically modified animals to become publicly available. The rights to GloFish are owned by Spectrum Brands, Inc., which purchased GloFish from Yorktown Technologies, the original developer of GloFish, in May 2017.

The ethics of technology is a sub-field of ethics addressing ethical questions specific to the technology age, the transitional shift in society wherein personal computers and subsequent devices provide for the quick and easy transfer of information. Technology ethics is the application of ethical thinking to growing concerns as new technologies continue to rise in prominence.

<span class="mw-page-title-main">Recombinant DNA</span> DNA molecules formed by human agency at a molecular level generating novel DNA sequences

Recombinant DNA (rDNA) molecules are DNA molecules formed by laboratory methods of genetic recombination that bring together genetic material from multiple sources, creating sequences that would not otherwise be found in the genome.

<span class="mw-page-title-main">Designer baby</span> Genetically modified human embryo

A designer baby is a baby whose genetic makeup has been selected or altered, often to exclude a particular gene or to remove genes associated with disease. This process usually involves analysing a wide range of human embryos to identify genes associated with particular diseases and characteristics, and selecting embryos that have the desired genetic makeup; a process known as preimplantation genetic diagnosis. Screening for single genes is commonly practiced, and polygenic screening is offered by a few companies. Other methods by which a baby's genetic information can be altered involve directly editing the genome before birth, which is not routinely performed and only one instance of this is known to have occurred as of 2019, where Chinese twins Lulu and Nana were edited as embryos, causing widespread criticism.

<span class="mw-page-title-main">Gene mapping</span> Process of locating specific genes

Gene mapping or genome mapping describes the methods used to identify the location of a gene on a chromosome and the distances between genes. Gene mapping can also describe the distances between different sites within a gene.

<span class="mw-page-title-main">Joan Slonczewski</span> American writer

Joan Lyn Slonczewski is an American microbiologist at Kenyon College and a science fiction writer who explores biology and space travel. Their books have twice earned the John W. Campbell Memorial Award for Best Science Fiction Novel: A Door into Ocean (1987) and The Highest Frontier (2011). With John W. Foster and Erik Zinser, they coauthor the textbook, Microbiology: An Evolving Science now in its fifth edition.

Gregory Stock is an American biophysicist, best-selling author, biotechnology entrepreneur, and the former director of the Program on Medicine, Technology and Society at UCLA School of Medicine. His interests lie in the scientific and evolutionary as well as ethical, social and political implications of today's revolutions in the life sciences and in information technology and computers.

<span class="mw-page-title-main">Lori Andrews</span> American professor of law

Lori B. Andrews is an American professor of law. She is on the faculty of Illinois Institute of Technology Chicago-Kent College of Law and serves as Director of IIT's Institute for Science, Law, and Technology. In 2002, she was a visiting professor at Princeton University. She received her B.A. summa cum laude from Yale College and her J.D. from Yale Law School. Andrews is a Fellow of the Hastings Center.

<i>Ulmus americana</i> American Liberty Elm cultivar

The American elm cultivar Ulmus americana 'American Liberty' is in fact a group of six genetically distinct cultivars under a single name, although they are superficially similar. The Liberty elm is reportedly suitable for street planting, being tolerant of de-icing salts and air pollution. However, examples included in 10-year trials at Atherton, California to evaluate replacements for Californian elms lost to disease did not perform well. The late Professor Eugene Smalley summarized 'American Liberty' as "not as resistant as the Asian hybrids, but it still has the look of a classic American Elm".

The genetics and abortion issue is an extension of the abortion debate and the disability rights movement. Since the advent of forms of prenatal diagnosis, such as amniocentesis and ultrasound, it has become possible to detect the presence of congenital disorders in the fetus before birth. Specifically, disability-selective abortion is the abortion of fetuses that are found to have non-fatal mental or physical defects detected through prenatal testing. Many prenatal tests are now considered routine, such as testing for Down syndrome. Women who are discovered to be carrying fetuses with disabilities are often faced with the decision of whether to abort or to prepare to parent a child with disabilities.

GenePeeks is a genetic research company that owns and runs Matchright, a simulation that determines the probability of genetic disorders being present in a child given two people's DNA.

Biotechnology risk is a form of existential risk from biological sources, such as genetically engineered biological agents. The release of such high-consequence pathogens could be

Human germline engineering (HGE) is the process by which the genome of an individual is modified in such a way that the change is heritable. This is achieved by altering the genes of the germ cells, which mature into eggs and sperm. For safety, ethical, and social reasons, the scientific community and the public have concluded that germline editing for reproduction is inappropriate. HGE is prohibited by law in more than 70 countries and by a binding international treaty of the Council of Europe.

<span class="mw-page-title-main">Genetics in fiction</span> Genetics as a theme in fiction

Aspects of genetics including mutation, hybridisation, cloning, genetic engineering, and eugenics have appeared in fiction since the 19th century.

<span class="mw-page-title-main">He Jiankui genome editing incident</span> 2018 scientific and bioethical controversy

The He Jiankui genome editing incident is a scientific and bioethical controversy concerning the use of genome editing following its first use on humans by Chinese scientist He Jiankui, who edited the genomes of human embryos in 2018. He became widely known on 26 November 2018 after he announced that he had created the first human genetically edited babies. He was listed in Time magazine's 100 most influential people of 2019. The affair led to ethical and legal controversies, resulting in the indictment of He and two of his collaborators, Zhang Renli and Qin Jinzhou. He eventually received widespread international condemnation.

<span class="mw-page-title-main">He Jiankui</span> Chinese scientist (born 1984)

He Jiankui is a Chinese biophysicist. He was named as the inaugural director of the Institute of Genetic Medicine at Wuchang Technical College, a private undergraduate college in Wuhan, in September 2023. Before January 2019, He served as associate professor at the Department of Biology of the Southern University of Science and Technology (SUSTech) in Shenzhen, Guangdong, China. Earning a PhD from Rice University in Texas on protein evolution, including that of CRISPR, He learned gene-editing techniques (CRISPR/Cas9) as a postdoctoral researcher at Stanford University in California.

References

  1. de Lange, Catherine (2014-04-06). "Startup offering DNA screening of 'hypothetical babies' raises fears over designer children". The Guardian. Retrieved 2014-04-16.

Bibliography